Tempest Therapeutics Ownership | Who Owns Tempest Therapeutics?


OverviewFinancialsChart

Tempest Therapeutics Ownership Summary


Tempest Therapeutics is owned by 10.97% institutional investors, 0.24% insiders, and 88.79% retail investors. Blackrock is the largest institutional shareholder, holding 2.47% of TPST shares. Fidelity Extended Market Index is the top mutual fund, with 0.52% of its assets in Tempest Therapeutics shares.

TPST Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockTempest Therapeutics10.97%0.24%88.79%
SectorHealthcare Stocks 88.01%8.90%3.09%
IndustryBiotech Stocks 109.70%8.77%-18.47%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Blackrock550.24K2.47%$1.21M
Fmr431.93K1.94%$945.93K
Vanguard group176.19K0.79%$385.86K
Geode capital management154.24K0.69%$337.83K
Fil129.58K0.58%$283.78K
Ikarian capital105.60K0.47%$231.26K
Gsa capital partners llp101.04K0.45%$221.00K
Morgan stanley62.74K0.28%$137.39K
Virtu financial62.03K0.28%$136.00K
Bank of america corp /de/43.26K0.19%$94.73K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Ikarian capital105.60K0.04%$231.26K
Gsa capital partners llp101.04K0.02%$221.00K
Virtu financial62.03K0.01%$136.00K
Maytech global investments10.00K0.00%$21.90K
Tocqueville asset management40.75K0.00%$89.24K
Boothbay fund management24.57K0.00%$53.81K
Fil129.58K0.00%$283.78K
Davenport50.00K0.00%$41.73K
Fmr431.93K0.00%$945.93K
Advisor group25.38K0.00%$55.56K

Top Buyers

HolderShares% AssetsChange
Gsa capital partners llp101.04K0.02%101.04K
Blackrock550.24K-42.05K
Virtu financial62.03K0.01%33.45K
Tocqueville asset management40.75K0.00%26.75K
Morgan stanley62.74K-25.95K

Top Sellers

HolderShares% AssetsChange
Simplex trading---37.82K
Empower advisory group---35.00K
Susquehanna group, llp---23.16K
Jane street group---21.04K
Bank of montreal /can/---20.00K

New Positions

HolderShares% AssetsChangeValue
Gsa capital partners llp101.04K0.02%101.04K$221.00K
Dimensional fund advisors lp25.08K-25.08K$54.93K
Parallel advisors236.00-236.00$517.00
Global retirement partners5.00-5.00$4.00

Sold Out

HolderChange
Whittier trust-2.00
Whittier trust co of nevada-11.00
Qube research-27.00
Wells fargo & company/mn-98.00
Ubs group-921.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Sep 30, 20243228.00%2,830,70931.84%1011.76%138.33%525.00%
Jun 30, 202425-21.88%2,147,12215.17%96.60%12-20.00%4-20.00%
Mar 31, 202432-11.11%1,864,298-15.77%124.92%15-42.31%5-
Dec 31, 20233650.00%2,213,399-35.12%152.68%26225.00%5-28.57%
Sep 30, 2023249.09%3,411,773-10.86%243.13%8-38.46%7133.33%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Fidelity Extended Market Index226.20K0.52%104.83K
Vanguard Institutional Extnd Mkt Idx Tr174.01K0.40%-
BlackRock Extended Equity Market K36.10K0.14%-15.00
Northern Trust Extended Eq Market Idx58.95K0.14%47.46K
NT Ext Equity Mkt Idx Fd - L58.95K0.14%47.46K
Fidelity Total Market Index43.37K0.10%-
Fidelity Series Total Market Index42.61K0.10%13.47K
iShares Micro-Cap ETF40.81K0.09%-
Extended Equity Market Fund K35.61K0.08%-490.00
Spartan Extended Market Index Pool E34.32K0.08%17.30K

Recent Insider Transactions


DateNameRoleActivityValue
Aug 08, 2024Versant Venture Capital VI, L.P.-Sell$540.04K
Aug 12, 2024Versant Venture Capital VI, L.P.-Sell$426.99K
Jul 03, 2024Brady Stephen R President and CEOBuy$73.85K
Jul 02, 2024Whiting Samuel Chief Medical OfficerBuy$9.95K
Jun 28, 2024Trojanowski Justin Corporate ControllerBuy$16.20K

Insider Transactions Trends


DateBuySell
2024 Q322
2024 Q21-
2024 Q1--
2023 Q4--
2023 Q2--

TPST Ownership FAQ


Who Owns Tempest Therapeutics?

Tempest Therapeutics shareholders are primarily institutional investors at 10.97%, followed by 0.24% insiders and 88.79% retail investors. The average institutional ownership in Tempest Therapeutics's industry, Biotech Stocks , is 109.70%, which Tempest Therapeutics falls below.

Who owns the most shares of Tempest Therapeutics?

Tempest Therapeutics’s largest shareholders are Blackrock (550.24K shares, 2.47%), Fmr (431.93K shares, 1.94%), and Vanguard group (176.19K shares, 0.79%). Together, they hold 5.21% of Tempest Therapeutics’s total shares outstanding.

Does Blackrock own Tempest Therapeutics?

Yes, BlackRock owns 2.47% of Tempest Therapeutics, totaling 550.24K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 1.21M$. In the last quarter, BlackRock increased its holdings by 42.05K shares, a 8.27% change.

Who is Tempest Therapeutics’s biggest shareholder by percentage of total assets invested?

Ikarian capital is Tempest Therapeutics’s biggest shareholder by percentage of total assets invested, with 0.04% of its assets in 105.6K Tempest Therapeutics shares, valued at 231.26K$.

Who is the top mutual fund holder of Tempest Therapeutics shares?

Fidelity Extended Market Index is the top mutual fund holder of Tempest Therapeutics shares, with 0.52% of its total shares outstanding invested in 226.2K Tempest Therapeutics shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools